BIOCHEMICAL-CHARACTERIZATION OF SR48692, A SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROTENSIN RECEPTOR

被引：0
|
作者：
OURYDONAT, F [1 ]
HEAULME, M [1 ]
THURNEYSSEN, O [1 ]
GONALONS, N [1 ]
GULLY, D [1 ]
LEFUR, G [1 ]
SOUBRIE, P [1 ]
机构：
[1] SANOFI RECH,F-34082 MONTPELLIER,FRANCE
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：U122 / U122
页数：1
相关论文
共 50 条
  • [1] Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692
    Iwase, K
    Evers, BM
    Hellmich, MR
    Kim, HJ
    Higashide, S
    Gully, D
    Thompson, JC
    Townsend, CM
    CANCER, 1997, 79 (09) : 1787 - 1793
  • [2] Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin
    Gully, D
    Lespy, L
    Canton, M
    Rostene, W
    Kitabgi, P
    LeFur, G
    Maffrand, JP
    LIFE SCIENCES, 1996, 58 (08) : 665 - 674
  • [3] The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay
    Thomas, James B.
    Navarro, Hernan
    Warner, Keith R.
    Gilmour, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1438 - 1441
  • [4] THE NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST SR48692 IS NOT A POTENT ANTAGONIST OF NEUROTENSIN(8-13) RESPONSES OF RAT SUBSTANTIA-NIGRA NEURONS IN-VITRO
    PINNOCK, RD
    WOODRUFF, GN
    NEUROSCIENCE LETTERS, 1994, 172 (1-2) : 175 - 178
  • [5] Neurotensin antagonist SR48692, potential radiosensitizer for prostate cancer
    Pemberton, Brad
    Parsons, J. T.
    Amorino, George
    CANCER RESEARCH, 2009, 69
  • [6] Neurotensin receptor antagonist, SR48692, sensitizes prostate cancer cells to radiation in vitro and in vivo
    Casarez, Eli V.
    DaSilva, John O.
    Valerie, Nicholas C. K.
    Anaganti, Suresh
    Dunlap-Brown, Marya E.
    Amorino, George P.
    Larner, James M.
    Parsons, Sarah J.
    Dziegielewski, Jaroslaw
    CANCER RESEARCH, 2011, 71
  • [7] THE NONPEPTIDE NEUROTENSIN ANTAGONIST, SR-48692 USED AS A TOOL TO REVEAL PUTATIVE NEUROTENSIN RECEPTOR SUBTYPES
    DUBUC, I
    COSTENTIN, J
    TERRANOVA, JP
    BARNOUIN, MC
    SOUBRIE, P
    LEFUR, G
    ROSTENE, W
    KITABGI, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) : 352 - 354
  • [8] The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice
    Costa, FG
    Frussa, R
    Felicio, LF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 428 (01) : 97 - 103
  • [9] SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells
    Moody, TW
    Chiles, J
    Casibang, M
    Moody, E
    Chan, D
    Davis, TP
    PEPTIDES, 2001, 22 (01) : 109 - 115
  • [10] SR-48692, A NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST, BLOCKS THE CARDIOVASCULAR EFFECTS ELICITED BY NEUROTENSIN IN GUINEA-PIGS
    NISATO, D
    GUIRAUDOU, P
    BARTHELEMY, G
    GULLY, D
    LEFUR, G
    LIFE SCIENCES, 1994, 54 (07) : PL95 - PL100
12345